Aggrastat

Aggrastat (Tirofiban Hydrochloride Monohydrate) is an intravenous medication used to prevent blood clots. It is commonly used during certain heart procedures to reduce the risk of clotting.

Aggrastat is primarily used to prevent blood clots in patients undergoing certain heart procedures, such as angioplasty. It works by inhibiting platelet aggregation, which helps to keep blood flowing smoothly. This medication is often used in combination with other treatments to manage heart-related conditions.

Aggrastat may cause common side effects such as nausea, headache, and bleeding at the injection site. Some patients may also experience dizziness or low blood pressure. These effects are generally mild and temporary, but any severe or persistent symptoms should be reported to a healthcare provider.

Aggrastat should be used with caution in patients with a history of bleeding disorders or recent surgery. It is important to monitor for signs of bleeding while using this medication. Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions.

Aggrastat may interact with other medications that affect blood clotting, such as anticoagulants and antiplatelet drugs. It is also important to avoid alcohol while using this medication, as it can increase the risk of bleeding. Always consult a healthcare provider before starting or stopping any medication.